117 related articles for article (PubMed ID: 18019621)
1. PET in colorectal cancer.
Dresel S; Schlag PM
Recent Results Cancer Res; 2008; 170():109-24. PubMed ID: 18019621
[No Abstract] [Full Text] [Related]
2. Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.
Strasberg SM; Dehdashti F
J Surg Oncol; 2010 Dec; 102(8):955-9. PubMed ID: 21165998
[TBL] [Abstract][Full Text] [Related]
3. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
Laurens ST; Oyen WJ
PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
[TBL] [Abstract][Full Text] [Related]
4. Detection of stomach peritoneal infiltration in colorectal cancer using PET-FDG.
Domínguez Grande ML; Bueno JG; Fernández JP; Suárez AM; Zomeño M; Oromendía AO; Kosvintseva O; Pozo MA
Clin Nucl Med; 2005 Feb; 30(2):122-3. PubMed ID: 15647685
[No Abstract] [Full Text] [Related]
5. Positron emission tomography with F-18 fluorodeoxyglucose in evaluating colorectal hepatic metastasis down-staged by chemotherapy.
Takahashi S; Kuroki Y; Nasu K; Nawano S; Konishi M; Nakagohri T; Gotohda N; Saito N; Kinoshita T
Anticancer Res; 2006; 26(6C):4705-11. PubMed ID: 17214330
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF
Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography and colorectal carcinoma: an update.
Tzimas GN; Koumanis DJ; Meterissian S
J Am Coll Surg; 2004 Apr; 198(4):645-52. PubMed ID: 15051018
[No Abstract] [Full Text] [Related]
8. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Donswijk ML; Hess S; Mulders T; Lam MG
PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
[TBL] [Abstract][Full Text] [Related]
9. Fluorine-18-fluorodeoxyglucose uptake of bone marrow on PET/CT can predict prognosis in patients with colorectal cancer after curative surgical resection.
Lee JW; Baek MJ; Ahn TS; Lee SM
Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):187-194. PubMed ID: 29120905
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
[TBL] [Abstract][Full Text] [Related]
11. PET-scan in colorectal cancer.
Lonneux M
Acta Chir Belg; 2005 Aug; 105(4):333-7. PubMed ID: 16184712
[TBL] [Abstract][Full Text] [Related]
12. PET-CT accurately predicts the pre-operative characteristics of colorectal hepatic metastases.
Jones C; Badger SA; McKie LD; Diamond T; Taylor MA; Lynch TB
Eur J Surg Oncol; 2012 Dec; 38(12):1184-8. PubMed ID: 22883963
[TBL] [Abstract][Full Text] [Related]
13. Survival of patients staged by FDG-PET before resection of hepatic metastases from colorectal cancer.
Strasberg SM; Siegal BA
Ann Surg; 2002 Feb; 235(2):308; author reply 310. PubMed ID: 11807374
[No Abstract] [Full Text] [Related]
14. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study.
Strasberg SM; Dehdashti F; Siegel BA; Drebin JA; Linehan D
Ann Surg; 2001 Mar; 233(3):293-9. PubMed ID: 11224615
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET for the pre-operative evaluation of colorectal liver metastases.
Arulampalam TH; Francis DL; Visvikis D; Taylor I; Ell PJ
Eur J Surg Oncol; 2004 Apr; 30(3):286-91. PubMed ID: 15028310
[TBL] [Abstract][Full Text] [Related]
16. A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables.
Tan MC; Castaldo ET; Gao F; Chari RS; Linehan DC; Wright JK; Hawkins WG; Siegel BA; Delbeke D; Pinson CW; Strasberg SM
J Am Coll Surg; 2008 May; 206(5):857-68; discussion 868-9. PubMed ID: 18471711
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography and colorectal cancer.
Arulampalam TH; Costa DC; Loizidou M; Visvikis D; Ell PJ; Taylor I
Br J Surg; 2001 Feb; 88(2):176-89. PubMed ID: 11167864
[TBL] [Abstract][Full Text] [Related]
18. Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?
Ramos E; Valls C; Martinez L; Lladó L; Torras J; Ruiz S; Gamez C; Serrano T; Fabregat J; Rafecas A
Ann Surg Oncol; 2011 Sep; 18(9):2654-61. PubMed ID: 21431987
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study.
Sørensen M; Mortensen FV; Høyer M; Vilstrup H; Keiding S;
Scand J Surg; 2007; 96(3):209-13. PubMed ID: 17966746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]